Last reviewed · How we verify
prevention of eclampsia in patients with preeclampsia
Approved treatments
Clinical guidelines
- FDA label — 1L
Magnesium Sulfate in 5% Dextrose Injection is indicated for the prevention of eclampsia in patients with preeclampsia. - FDA label — 1L
Magnesium Sulfate in 5% Dextrose Injection is indicated for the treatment of seizures in patients with eclampsia. - FDA label — 1L
Magnesium Sulfate in 5% Dextrose Injection is indicated for the prevention of recurrent seizures in patients with eclampsia.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- prevention of eclampsia in patients with preeclampsia patent landscape — cliff calendar, originator estates, attackable patents
- prevention of eclampsia in patients with preeclampsia treatment landscape brief
- prevention of eclampsia in patients with preeclampsia treatment updates RSS
Frequently asked questions about prevention of eclampsia in patients with preeclampsia
What are the treatment guidelines for prevention of eclampsia in patients with preeclampsia?
FDA label publishes guidelines for prevention of eclampsia in patients with preeclampsia. 3 guideline references tracked.